PM asks states to gear up for COVID-19 vaccine distribution
Russian developers claim 95% efficacy in interim results of Sputnik V
Coronavirus update: India tally crosses 8 million mark
Global tally crosses 44 million mark
COVID-19: Trials for cure at a glance
Scientists across the globe are working to develop vaccines for the novel coronavirus disease while exploring whether existing drugs can be …
India finally gives in on TRIPS waiver
The WTO agreement on a limited patents waiver merely restates exemptions already available under existing rules
Need to ramp up vaccine supply for developing countries: Global task force on COVID-19
Heads of the World Bank Group, International Monetary Fund, World Health Organization and World Trade Organization met for the first time …
Covaxin effective against UK Strain: What does this mean in absence of efficacy data?
Being a whole-virus vaccine doesn’t give Bharat Biotech product any advantage at this stage, say experts
Why experts are not happy with India’s COVID-19 vaccine procurement, pricing policy
India only COVID-19 vaccine producer that has shifted burden onto citizens to pay for vaccines by opening private markets for them, experts say
COVID-19: Spike in infections, new variant raise worry in South Africa
The new variant is now dominant, responsible for 99 per cent of all positive COVID-19 cases in the country
COVID-19 vaccine update: Nearly 35 million jabs administered in India so far
Xi Jinping announces he will start regular visa services for those administered the China-made vaccine; no such vaccine is, however, available in …
Is SARS-CoV-2 becoming more stable? A new study tracks virus’ evolution
The virus also showed signs of stabilising around some proteins, according to the study
COVID-19: Where India stands 6 months since Modi called for lockdown
As the country marks six months since the COVID-19 lockdown was imposed, its metropolitan cities have resumed public transport and offices, …
WTO members agree to discuss proposal to waive patents on COVID-19 technologies
The waiver would increase access to technologies crucial to fighting the pandemic
Vaccine Scarcity: Government projection of vaccine demand goes haywire
Not expecting second surge, Centre exported more than 60 million doses
Watch out for new COVID-19 strain, warns Niti Aayog’s Paul
Priority genome sequencing for those landing from the UK amid heightened surveillance
Why COVID-19 will not kill off global business travel
In medium term, life sciences companies will continue to expand and view travel as a vital channel for maintaining new business in markets
No COVID-19 vaccine before 2021, Centre puts out then deletes
Sentence in question inadvertently included: PIB official; Things are contextual, says author of original article
Kerala HC directs NDMA to formulate compensation policy for those dying due to COVID-19 vaccine
The order was passed September 1 and a time frame of three months has been set; the move sets a precedent since no such policy has been …
A vaccine only for Omicron: Does India really need it?
Experts bat for considering benefits, economics carefully before spending on bivalent shots
Gujarat recipients gung-ho on COVID-19 vaccine
The state will vaccinate about 440,000 healthcare workers and 355,000 frontline workers in the first round
West Bengal rolls out COVID-19 vaccines even as politics creeps in
Political parties blame each other of ‘vaccine theft’ in the poll-bound state
COVID-19 immunity: how long does it last?
In UK’s second wave, previously infected health workers were either completely protected from reinfection or were asymptomatic
First 2 phases of Russian vaccine trial indicate safety and efficacy: Study
Two formulations of the vaccine have been developed: One could be introduced through global supply chain and other in hard-to-reach regions
COVID-19: Phase 3 of vaccine developed by Chinese researchers underway, says Lancet
The Ad5-vectored COVID-19 vaccine tested on people above 55 years of age, is considered a step up from another vaccine being developed by the UK
COVID-19 vaccine update: People above 45 eligible for jabs from April 1
Ministry of Home Affairs releases updated guidelines for COVID-19 control
As told to Parliament (March 18, 2021): India has 75 Particularly Vulnerable Tribal Groups
All that was discussed in the House through the day